|
Acute coronary syndromes
Citations 51-60 of 958 total displayed.
|
Past content
(since Jan 1999):
|
- Coronary Heart Disease
Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome: Results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) Trial
- APPRAISE Steering Committee and Investigators
Circulation 2009;119:2877-2885; published online before print as doi:10.1161/CIRCULATIONAHA.108.832139
[Abstract]
[Full text]
- Articles
Comparison of Primary Percutaneous Coronary Intervention and Fibrinolytic Therapy in ST-Segment–Elevation Myocardial Infarction. Bayesian Hierarchical Meta-Analyses of Randomized Controlled Trials and Observational Studies
- Thao Huynh, Stephane Perron, Jennifer O'Loughlin, Lawrence Joseph, Michel Labrecque, Jack V. Tu, and Pierre Théroux
Circulation published June 8, 2009, doi:10.1161/CIRCULATIONAHA.108.793745
[Abstract]
- Clinician Update
Can We Override Clopidogrel Resistance?
- Ana Pena, Jean-Philippe Collet, Jean-Sébastien Hulot, Johanne Silvain, Olivier Barthélémy, Farzin Beygui, Christian Funck-Brentano, and Gilles Montalescot
Circulation 2009;119:2854-2857, doi:10.1161/CIRCULATIONAHA.108.857722
[Full text]
- Articles
Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome. Results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) Trial
- APPRAISE Steering Committee and Investigators
Circulation published May 26, 2009, doi:10.1161/CIRCULATIONAHA.108.832139
[Abstract]
- Genetics
Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel: Relationship to Pharmacokinetic, Pharmacodynamic, and Clinical Outcomes
- Jessica L. Mega, Sandra L. Close, Stephen D. Wiviott, Lei Shen, Richard D. Hockett, John T. Brandt, Joseph R. Walker, Elliott M. Antman, William L. Macias, Eugene Braunwald, and Marc S. Sabatine
Circulation 2009;119:2553-2560; published online before print as doi:10.1161/CIRCULATIONAHA.109.851949
[Abstract]
[Full text]
- Resuscitation Science
Improved Patient Survival Using a Modified Resuscitation Protocol for Out-of-Hospital Cardiac Arrest
- Alex G. Garza, Matthew C. Gratton, Joseph A. Salomone, Daniel Lindholm, James McElroy, and Rex Archer
Circulation 2009;119:2597-2605; published online before print as doi:10.1161/CIRCULATIONAHA.108.815621
[Abstract]
[Full text]
- Editorials
Adverse Prognostic Significance of Thrombocytopenia in Acute Coronary Syndrome: Can Anything Be Done About It?
- Theodore E. Warkentin and Mark A. Crowther
Circulation 2009;119:2420-2422, doi:10.1161/CIRCULATIONAHA.109.858316
[Full text]
- Coronary Heart Disease
Incidence and Prognostic Significance of Thrombocytopenia Developed During Acute Coronary Syndrome in Contemporary Clinical Practice
- Tracy Y. Wang, Fang-Shu Ou, Matthew T. Roe, Robert A. Harrington, E. Magnus Ohman, W. Brian Gibler, and Eric D. Peterson
Circulation 2009;119:2454-2462; published online before print as doi:10.1161/CIRCULATIONAHA.108.827162
[Abstract]
[Full text]
- Correspondence
Letter by Bouzas-Mosquera et al Regarding Article, "Cardiac Magnetic Resonance With T2-Weighted Imaging Improves Detection of Patients With Acute Coronary Syndrome in the Emergency Department"
- Alberto Bouzas-Mosquera, Jesús Peteiro, and Nemesio Álvarez-García
Circulation 2009;119:e523, doi:10.1161/CIRCULATIONAHA.108.813931
[Full text]
- Correspondence
Response to Letter Regarding Article, "Cardiac Magnetic Resonance With T2-Weighted Imaging Improves Detection of Patients With Acute Coronary Syndrome in the Emergency Department"
- Ricardo C. Cury, Khalid Shash, Guido Rosito, Michael D. Shapiro, Cesar H. Nomura, Suhny Abbara, Fabian Bamberg, Maros Ferencik, Ehud J. Schmidt, Udo Hoffmann, Thomas J. Brady, John T. Nagurney, and David F. Brown
Circulation 2009;119:e524, doi:10.1161/CIRCULATIONAHA.108.830893
[Full text]
|
|
